Secalip and alanine aminotransferase increased Patient Reports February 11, 2012
Secalip Side Effects Report #4625515-2
Secalip side effect was reported by a Consumer or non-health professional from on Mar 01, 2005. Male patient, 67 years of age, was diagnosed with dyslipidaemia, gastrooesophageal reflux disease, pain
, infection prophylaxis, benign prostatic hyperplasia and was treated with Secalip. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, arthropathy, aspartate aminotransferase increased, haematuria, muscle disorder
, pain in extremity, proteinuria, pyogenic granuloma. Secalip dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, ACETAMINOPHEN W, CLOXACILLIN, ALFUZOSIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Secalip Side Effects Report #4662032-8
Secalip side effect was reported by a Consumer or non-health professional from on Mar 01, 2005. Male patient, 67 years of age, was diagnosed with dyslipidaemia, anaesthesia, gastrooesophageal reflux disease, pain
, infection prophylaxis and was treated with Secalip. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthropathy, aspartate aminotransferase increased, haematuria, muscle disorder
, pain in extremity, proteinuria, pyogenic granuloma. Secalip dosage: unknown. During the same period patient was treated with SEVORANE LIQUID INHALATION, PANTOPRAZOLE, ACETAMINOPHEN W, CLOXACILLIN, ATROPINE, MIDAZOLAM HYDROCHLORIDE, KETAMINE, PROPOFOL. Patient was hospitalized. Patient recovered.Secalip Side Effects Report #4676724-8
Secalip side effect was reported by a Consumer or non-health professional from on Mar 01, 2005. Male patient, 67 years of age, weighting 165.3 lb, was diagnosed with dyslipidaemia, anaesthesia, gastrooesophageal reflux disease, pain
, infection prophylaxis and was treated with Secalip. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthropathy, aspartate aminotransferase increased, haematuria, muscle disorder
, pain in extremity, proteinuria, pyogenic granuloma. Secalip dosage: unknown. During the same period patient was treated with SEVORANE LIQUID INHALATION, PANTOPRAZOLE, ACETAMINOPHEN W, CLOXACILLIN, ATROPINE, MIDAZOLAM HYDROCHLORIDE, KETAMINE. Patient was hospitalized. Patient recovered.Secalip Side Effects Report #4704858-8
Secalip side effect was reported by a Consumer or non-health professional from FRANCE on Mar 01, 2005. Male patient, 67 years of age, weighting 165.3 lb, was diagnosed with dyslipidaemia, anaesthesia, gastrooesophageal reflux disease, pain
, infection prophylaxis and was treated with Secalip. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthropathy, aspartate aminotransferase increased, haematuria, muscle disorder
, pain in extremity, proteinuria, pyogenic granuloma. Secalip dosage: unknown. During the same period patient was treated with SEVORANE LIQUID INHALATION, INIPOMP, ACETAMINOPHEN W, CLOXACILLIN, ATROPINE, MIDAZOLAM HYDROCHLORIDE, KETAMINE. Patient was hospitalized. Patient recovered.Secalip Side Effects Report #4741554-5
Secalip side effect was reported by a Consumer or non-health professional from FRANCE on Mar 01, 2005. Male patient, weighting 165.3 lb, was diagnosed with dyslipidaemia, anaesthesia, gastrooesophageal reflux disease, pain
, infection prophylaxis and was treated with Secalip. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthropathy, aspartate aminotransferase increased, haematuria, muscle disorder
, pain in extremity, proteinuria, pyogenic granuloma. Secalip dosage: unknown. During the same period patient was treated with SEVORANE LIQUID INHALATION, INIPOMP, ACETAMINOPHEN W, CLOXACILLIN, ATROPINE, MIDAZOLAM HYDROCHLORIDE, KETAMINE. Patient was hospitalized. Patient recovered.
Secalip and alanine aminotransferase increased 